4.6 Article

The HER2-Binding Affibody Molecule (ZHER2:342)2 Increases Radiosensitivity in SKBR-3 Cells

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules

Richard P. Baum et al.

JOURNAL OF NUCLEAR MEDICINE (2010)

Article Multidisciplinary Sciences

Structural basis for high-affinity HER2 receptor binding by an engineered protein

Charles Eigenbrot et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biology

NF-κB-Mediated HER2 Overexpression in Radiation-Adaptive Resistance

Ning Cao et al.

RADIATION RESEARCH (2009)

Review Oncology

Receptor signaling as a regulatory mechanism of DNA repair

Raymond E. Meyn et al.

RADIOTHERAPY AND ONCOLOGY (2009)

Article Biochemistry & Molecular Biology

Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line

Lina Ekerljung et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Differences in radiosensitivity between three HER2 overexpressing cell lines

Ann-Charlott Steffen et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)

Article Cell Biology

Mapping ErbB receptors on breast cancer cell membranes during signal transduction

Shujie Yang et al.

JOURNAL OF CELL SCIENCE (2007)

Review Chemistry, Medicinal

Targeting the epidermal growth factor receptor family in radionuclide therapy of tumors-signal transduction and DNA repair

Johan Lennartsson et al.

LETTERS IN DRUG DESIGN & DISCOVERY (2006)

Article Chemistry, Inorganic & Nuclear

Measuring the affinity of a radioligand with its receptor using a rotating cell dish with in situ reference area

H Bjorke et al.

APPLIED RADIATION AND ISOTOPES (2006)

Article Oncology

Signal transduction and oncogenesis by ErbB/HER receptors

MD Marmor et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)

Review Pharmacology & Pharmacy

Strategies to target HER2/neu overexpression for cancer therapy

JS Chen et al.

DRUG RESISTANCE UPDATES (2003)